NCI R21: Exploratory Cancer Research and Early Clinical Development (Clinical Trial Optional)
The National Cancer Institute invites R21 applications for exploratory and developmental cancer research across diagnosis, treatment, imaging, symptom/toxicity, and prevention. Projects may include correlative studies, novel therapeutics and radiotherapy, mechanism-driven combinations, and innovative preclinical models or imaging that could lead to first-in-human trials. Clinical trials are op…
Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) intends to supports the development of new exploratory research in cancer diagnosis, treatment, imaging, symptom/toxicity, and prevention clinical trials; correlative studies associated with clinical trials; n…
Funding Source
Awards & funding
Eligibility
Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving …
Supporting links
Documents
Secure Grant Funding 10x Faster
Scout delivers AI-powered grant writing paired with experts that's faster, more affordable, and built to win.
Already have an account? Sign In
Trusted by 500+ Happy Customers